STERIS Stock Forecast, Price & News

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" STERIS stock.
View analyst ratings for STERIS or view top-rated stocks.

Wall Street analysts have given STERIS a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but STERIS wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

STERIS is scheduled to release its next quarterly earnings announcement on Monday, November 1st 2021.
View our earnings forecast for STERIS.

STERIS plc (NYSE:STE) announced its earnings results on Monday, August, 9th. The medical equipment provider reported $1.76 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.49 by $0.27. The medical equipment provider earned $968.40 million during the quarter, compared to the consensus estimate of $904.90 million. STERIS had a net margin of 8.39% and a trailing twelve-month return on equity of 12.81%. The firm's quarterly revenue was up 44.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.31 earnings per share.
View STERIS's earnings history.

STERIS's stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, STE shares have increased by 46.3% and is now trading at $212.52.
View which stocks have been most impacted by COVID-19.

STERIS declared a quarterly dividend on Monday, August 9th. Shareholders of record on Friday, September 3rd will be paid a dividend of $0.43 per share on Friday, September 24th. This represents a $1.72 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date is Thursday, September 2nd. This is an increase from STERIS's previous quarterly dividend of $0.40.
View STERIS's dividend history.

STERIS pays an annual dividend of $1.72 per share and currently has a dividend yield of 0.80%. The dividend payout ratio of STERIS is 27.88%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STERIS will have a dividend payout ratio of 19.84% next year. This indicates that STERIS will be able to sustain or increase its dividend.
View STERIS's dividend history.

STERIS issued an update on its FY 2022 earnings guidance on Monday, September, 6th. The company provided earnings per share (EPS) guidance of $7.600-$7.850 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.410. The company issued revenue guidance of $4.60 billion-$4.60 billion, compared to the consensus revenue estimate of $4.33 billion.

6 brokers have issued 12 month target prices for STERIS's shares. Their forecasts range from $233.00 to $255.00. On average, they expect STERIS's share price to reach $242.40 in the next twelve months. This suggests a possible upside of 14.1% from the stock's current price.
View analysts' price targets for STERIS or view top-rated stocks among Wall Street analysts.

196 employees have rated STERIS CEO Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among STERIS's employees.

Some companies that are related to STERIS include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), Baxter International (BAX), Insulet (PODD), Hologic (HOLX), Teleflex (TFX) and Abiomed (ABMD).
View all of STE's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), The Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

STERIS's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (12.57%), BlackRock Inc. (9.12%), WCM Investment Management LLC (8.03%), Massachusetts Financial Services Co. MA (4.87%), State Street Corp (4.05%) and APG Asset Management N.V. (4.02%). Company insiders that own STERIS stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves and Walter M Rosebrough Jr.
View institutional ownership trends for STERIS.

STE stock was sold by a variety of institutional investors in the last quarter, including Great West Life Assurance Co. Can, Echo Street Capital Management LLC, Principal Financial Group Inc., Tekla Capital Management LLC, Millennium Management LLC, AQR Capital Management LLC, Los Angeles Capital Management LLC, and Frontier Capital Management Co. LLC. Company insiders that have sold STERIS company stock in the last year include Cary L Majors, Cynthia L Feldmann, David B Lewis, Jacqueline B Kosecoff, Julia Madsen, Karen L Burton, Renato Tamaro, and Walter M Rosebrough Jr.
View insider buying and selling activity for STERIS or view top insider-selling stocks.

STE stock was bought by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Champlain Investment Partners LLC, Vanguard Group Inc., American Century Companies Inc., State Street Corp, Credit Suisse AG, Marshall Wace North America L.P., and Price T Rowe Associates Inc. MD.
View insider buying and selling activity for STERIS or or view top insider-buying stocks.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of STE stock can currently be purchased for approximately $212.52.

STERIS has a market capitalization of $21.20 billion and generates $3.11 billion in revenue each year. The medical equipment provider earns $397.40 million in net income (profit) each year or $6.17 on an earnings per share basis.

STERIS employs 13,000 workers across the globe.

STERIS was founded in 1987.

The official website for STERIS is www.steris.com.

STERIS is headquartered at 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296.

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at (531) 232-2000 or via email at [email protected].